Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Leila Vali

Leila Vali

Kuwait University, Kuwait

Title: Clonal spread of Staphylococcus aureus isolates with reduced sensitivity to chlorhexidine in Kuwaiti hospitals

Biography

Biography: Leila Vali

Abstract

It is essential to reduce the bacterial load and ensure the effectiveness of hygienic conditions in hospitals. Chlorhexidine is one of the most widely used biocides. Since resistance genes to quaternary ammonium compounds have appeared more frequently in staphylococci, we aimed to identify S. aureus with reduced sensitivity to Chlorhexidine in Kuwaiti hospitals. We collected 97 methicillin-resistant (MRSA) and 100 methicillin-sensitive (MSSA) S. aureus. We amplified mecA, blaZ, qac A/B, qacH, qacH2, qacG, smr, norA, PVL and agr genes. Antibiotic sensitivity testing for 10 antibiotics and MIC/MBC of chlorhexidine were determined. MLST, spa typing and PFGE were used to identify genetic variations. The predominant genes were mecA, blaZ, norA, qacA/B, smr, while qacG, qacH, qacH2 were not detected. All isolates were sensitive to vancomycin, teicoplanin and tigecycline. The range of MIC for chlorhexidine for qacA/B positive isolates was 4-30 mg/l, however the MBC (0.94-60 mg/l) was statistically greater than MIC (p˂0.0001). Typing methods showed all the isolates with reduced sensitivity to chlorhexidine containing qacA were ST239-III-t945-PVL˗. The presence of qac genes does not necessarily imply increased resistance to chlorhexidine or any other antimicrobial agents. However MBC of chlorhexidine was higher for the isolates containing qacA/B compared to those without. We observed clonality among the qacA/B positive isolates with reduced sensitivity to chlorhexidine (HA-MRSA-ST239-III-t945 PVL˗). Reduced sensitivity may be a contributing factor to survival of this clone in hospitals. It is crucial to strictly monitor dilution standards to avoid low level exposure of HA-MRSA-ST239-III to biocides, specifically in the developing countries.